Benign neoplasm: Connective and other soft tissue of abdomen

CD2_BENIGN_CONNSOFT_ABD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D21.4& Hospital discharge: ICD-9 — 2155 Cause of death: ICD-10 — D21.4& Cause of death: ICD-9 — 2155 2 out of 7 registries used, show all original rules.	112
4. Check minimum number of events None	112
5. Include endpoints None	112
6. Filter based on genotype QC (FinnGen only)	95

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D21
Name in latin: Neoplasma benignum textus connectivi abdominis

NAME	CD2_BENIGN_CONNSOFT_ABD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D214
HD_ICD_9	2155
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D214
COD_ICD_9	2155
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Connective and other soft tissue of abdomen based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	814	549	263
Only index persons	728	504	224
Unadjusted period prevalence (%)
Whole population	0.01	0.02	0.01
Only index persons	0.02	0.02	0.01
Median age at first event (years)
Whole population	46.06	43.94	50.31
Only index persons	44.26	42.22	48.84

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	95	65	30
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	47.91	42.85	58.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
103: Matched controls
1030

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D21.4

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue of abdomen

3573.3

102.9

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

10.3

21.5

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

+∞

10.6

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

20.3

7.8

2155X

ICD-9 Finland

Other benign neoplasm of connective and other soft tissue, Abdomen[ABDOMENIN BENIGNI PEHMYTKUDOSKASVAIN,TARK MÄÄRITTEL]

+∞

7.4

2155A

ICD-9 Finland

Other benign neoplasm of connective and other soft tissue, Abdomen[ABDOMENIN BENIGNI PEHMYTKUDOSKASVAIN,SIDEKUDOSPERÄI]

+∞

6.3

6141

FHL

Exploration or removal of a local change in the abdominal wall (umbilical cord, tumor, hematoma, endometrioma)

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

174

2.32

3.60

4.6

3.3

76.50

223.47

ng/l

0.42

130

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

111

2.52

3.47

1.8

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2.42

2.71

2.3

3.7

6.06

5.82

kpa

0.44

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

154

2.12

2.69

1.7

—

(3018418) pH of Serum or Plasma

280

1.92

2.58

3.2

4.3

7.39

7.40

0.38

208

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

690

2.18

2.45

4.1

4.7

13.83

11.34

mm/h

0.81

638

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

5.23

2.44

2.8

1.4

4.02

2.92

u/ml

—

(3002256) Pathology report gross observation

114

2.18

2.44

1.2

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

116

2.14

2.33

1.8

1.6

—

(3012544) pH of Venous blood

2.24

2.22

2.3

3.5

7.37

7.39

0.92

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.64

2.19

1.4

3.2

23.62

24.90

mmol/l

0.77

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.34

1.91

1.6

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.34

1.91

1.6

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

320

1.72

1.91

3.3

2.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

2.20

1.86

2.1

3.1

4.29

4.28

kpa

0.00

(3000991) Gas panel - Venous blood

2.17

1.80

9.9

8.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

186

1.78

1.74

1.6

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

541

1.68

1.70

9.3

9.6

4.16

4.17

e9/l

0.01

481

(42870588) Differential panel, method unspecified - Blood

311

1.66

1.67

5.2

5.6

—

(3030467) Casts [#/volume] in Urine by Automated count

240

1.69

1.66

3.9

3.3

0.61

0.38

e6/l

0.39

173

(3023368) Bacteria identified in Blood by Culture

232

1.69

1.64

6.7

3.9

—

(3000492) Spirometry study

2.12

1.63

1.4

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.25

1.62

1.4

—

(40768804) Tissue Pathology biopsy report

370

1.62

1.59

2.4

2.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

447

1.62

1.58

8.3

7.6

1.21

mmol/l

0.21

388

(3042936) Bacteria identified in Isolate by Culture

134

1.82

1.55

3.1

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

3.45

1.54

2.0

4.3

8.14

54.50

u/ml

—

(3002582) Erythrocytes [#/volume] in Urine

292

1.60

1.46

3.8

3.4

29.13

248.32

e6/l

0.50

227

(3013115) Eosinophils [#/volume] in Blood

502

1.59

1.46

6.2

0.18

e9/l

0.03

442

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

239

1.63

1.44

3.5

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

565

1.60

1.42

3.3

3.4

—

(40768797) Stomach Pathology biopsy report

138

1.76

1.41

1.3

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

495

1.57

1.40

5.9

6.1

2.06

1.91

e9/l

0.19

440

(3019977) pH of Arterial blood

107

1.83

1.37

11.1

7.7

7.43

7.42

—

(3011288) Drugs identified in Urine by Screen method Nominal

2.59

1.32

1.0

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.14

1.30

1.4

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

2.39

1.30

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.86

1.30

1.0

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

125

1.74

1.30

15.8

7.1

103.95

104.12

mmol/l

0.06

125

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2.32

1.27

1.0

1.2

—

7.58

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

194

1.61

1.25

1.4

9.63

30.47

iu/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

454

1.51

1.24

3.8

2.7

—

estimate

—

(3019150) Specific gravity of Urine by Refractometry

221

1.58

1.23

3.9

1.02

kg/l

0.04

153

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

111

1.75

1.22

3.5

4.2

274.94

236.65

u/l

0.51

103

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

417

1.50

1.20

7.2

6.4

1.21

mmol/l

0.27

386

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

179

1.61

1.18

1.2

1.4

0.99

7.99

u/ml

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

1.18

0.0

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

147

1.63

1.12

6.3

5.2

23.23

22.43

0.09

(3021589) Normoblasts [#/volume] in Blood

402

1.47

1.12

9.7

11.3

0.00

e9/l

0.50

320

(3028026) IgM [Mass/volume] in Serum or Plasma

1.90

1.10

1.5

1.27

1.28

g/l

0.01

(3026493) Urate [Moles/volume] in Serum or Plasma

227

1.52

1.08

2.1

2.8

358.08

336.03

umol/l

0.46

196

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

140

1.63

1.08

3.5

2.9

2.22

2.92

e6/l

—

(3018095) Leukocytes [#/volume] in Urine

338

1.47

1.07

4.4

4.1

168.42

47.79

e6/l

0.69

237

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

310

1.47

1.07

4.0

3.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

301

1.48

1.06

3.3

3.9

10.72

10.34

mg/mmol

0.01

185

(3001604) Monocytes [#/volume] in Blood

484

1.45

1.05

6.1

6.0

0.60

0.59

e9/l

0.14

419

(3006315) Basophils [#/volume] in Blood

485

1.45

1.03

6.1

0.04

e9/l

0.34

418

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

117

1.65

1.02

2.3

3.1

16.89

7.00

umol/l

0.54

101

(3020891) Body temperature

2.01

0.99

3.0

4.5

36.77

36.90

°c

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

152

1.57

0.99

3.5

2.8

0.60

1.25

e6/l

—

(3003694) ABO and Rh group [Type] in Blood

282

0.64

0.98

1.9

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

269

1.46

0.96

3.5

3.2

—

0.25

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.96

0.96

1.0

1.4

—

(3015736) pH of Urine

403

1.41

0.93

3.9

3.5

6.20

6.22

0.05

236

(3021601) Nitrite [Presence] in Urine by Test strip

502

1.41

0.92

4.1

4.0

0.00

estimate

—

107

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.13

0.91

1.0

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

831

1.66

0.90

6.9

6.3

39.51

39.15

mmol/mol

0.16

784

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

183

1.48

0.87

1.8

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

106

1.60

0.85

1.6

1.5

—

(3012516) Albumin [Mass/volume] in Urine

294

1.40

0.84

2.9

3.3

66.28

72.98

mg/l

0.04

188

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1.64

0.83

12.9

8.7

123.43

121.22

g/l

0.11

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.93

0.83

1.0

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.76

0.83

1.8

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

859

1.66

0.81

5.1

5.93

5.87

mmol/l

0.20

793

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.80

0.0

1.3

—

1.59

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.80

0.0

1.3

—

0.81

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.62

0.80

2.6

2.4

0.21

0.22

g/l

0.25

(3009508) Creatinine [Moles/volume] in Urine

315

1.38

0.80

2.7

3.1

6.58

7.61

mmol/l

1.20

261

(3009261) Glucose [Presence] in Urine by Test strip

510

1.37

0.79

4.2

4.1

0.00

estimate

—

100

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.76

0.78

1.3

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

126

1.52

0.77

1.9

1.5

—

(3026008) Bacteria identified in Urine by Culture

270

1.39

0.77

3.3

3.1

—

(3008037) Lactate [Moles/volume] in Venous blood

2.14

0.75

3.2

3.5

1.12

1.53

mmol/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

190

1.42

0.72

1.8

2.1

—

(3049717) Cytology report of Urine Cyto stain

1.89

0.69

1.2

2.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1.82

0.67

1.6

1.2

18.14

10.25

u/l

—

(3035350) Ketones [Presence] in Urine by Test strip

511

1.31

0.63

4.2

4.0

0.00

estimate

—

107

(40758558) Short blood count panel - Blood

279

1.33

0.61

6.1

7.0

—

(3019060) Gas panel - Arterial blood

1.55

0.60

1.8

5.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.5

—

(3000494) Fungus identified in Specimen by Culture

116

1.45

0.59

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1.52

0.57

2.8

3.1

72.80

67.06

ml/min/173m2

—

(4035726) Immunohistochemistry procedure

1.50

0.54

1.5

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.44

0.53

3.6

2.3

5.07

4.87

ug/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

353

1.27

0.51

3.1

4.2

22.60

40.36

ng/l

0.60

246

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

412

1.26

0.50

2.4

2.1

78.93

99.35

pmol/l

1.28

210

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.56

0.49

7.4

9.3

22.13

26.40

mmol/l

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.52

0.49

3.6

3.7

40.50

47.58

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

166

1.33

0.48

1.2

1.5

—

(40761511) CBC panel - Blood by Automated count

904

1.46

0.47

19.0

14.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

104

1.40

0.46

1.2

2.3

357.21

362.51

nmol/l

0.03

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.64

0.43

1.2

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

282

1.25

0.43

3.6

4.0

0.00

estimate

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.41

0.0

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.41

0.0

1.9

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.41

0.0

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.40

0.0

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

313

1.23

0.40

2.8

2.7

79.48

68.23

u/l

0.20

290

(3000764) Benzodiazepines [Presence] in Urine

1.45

0.40

1.2

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.45

0.40

1.8

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.40

0.40

5.0

4.7

4.43

4.66

pmol/l

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

247

1.24

0.39

1.5

1.3

0.74

1.30

u/ml

—

(3016879) Cocaine [Presence] in Urine

1.41

0.38

1.2

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

121

0.72

0.38

1.8

2.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

383

1.21

0.38

4.6

3.8

0.00

estimate

—

(1002224) Polysomnography panel

1.45

0.36

1.0

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1.42

0.35

3.5

3.7

25.35

24.81

mmol/l

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1.36

0.33

2.1

2.3

0.28

0.13

e6/l

0.60

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.40

0.32

2.9

2.7

0.61

0.64

—

(3019832) Treponema pallidum Ab [Presence] in Serum

111

1.30

0.32

1.6

1.9

—

(3037522) Nuclear Ab [Titer] in Serum

148

1.26

0.32

1.3

1.4

176.00

468.57

titre

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.34

0.31

21.0

7.0

15.83

16.08

—

(3032080) INR in Blood by Coagulation assay

428

1.18

0.31

17.6

12.8

1.23

1.18

inr

0.22

356

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.32

0.31

2.9

2.7

0.96

1.16

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

108

0.72

0.31

1.5

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.29

0.30

1.1

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.27

0.30

1.6

702.39

1030.12

mu/l

—

(3025941) Bacteria identified in Stool by Culture

1.31

0.29

1.0

1.3

—

(40761536) Microorganisms panel - Urine sediment

1.25

0.26

2.7

4.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

105

1.27

0.26

10.2

8.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.24

0.26

1.4

—

(3027944) Amphetamines [Presence] in Urine

1.33

0.23

1.2

1.4

—

(3027008) Opiates [Presence] in Urine

1.33

0.23

1.2

1.4

—

(3028300) Cannabinoids [Presence] in Urine

1.33

0.23

1.2

1.4

—

(40768443) Skin Pathology biopsy report

1.26

0.23

1.4

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.21

0.0

2.6

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.21

0.0

1.6

—

-0.86

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.21

0.0

1.4

—

8.55

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.6

—

(3018333) Ribosomal P Ab [Presence] in Serum

0.00

0.21

0.0

1.5

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

5.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

2.8

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.21

0.0

1.3

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

1.33

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

1.22

0.17

3.1

2.8

83.92

68.24

e9/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

105

0.84

0.13

1.6

1.8

—

(36660697) Celiac disease serology panel - Serum

1.19

0.13

1.3

1.2

—

(3008898) HLA-B27 [Presence]

1.14

0.10

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

124

0.87

0.09

3.9

4.9

32.33

32.23

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

378

0.93

0.09

2.0

1.42

1.37

mmol/l

0.12

318

(3004588) Protein electrophoresis panel - Serum or Plasma

1.08

0.09

2.7

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

113

0.87

0.09

1.1

1.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.15

0.08

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.06

0.08

2.0

1.6

—

(3025159) Blasts/Leukocytes in Blood

0.87

0.07

2.7

5.1

—

0.45

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.12

0.05

2.5

3.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

229

1.06

0.05

4.2

4.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

221

1.05

0.03

1.7

1.4

2.65

2.50

g/l

0.11

127

(3041096) Erythrocytes [Presence] in Urine by Automated

288

0.96

0.02

4.4

3.4

0.00

estimate

—

(1761868) Lipid panel - Serum or Plasma

344

0.98

0.00

4.1

3.2

—

(3022145) Colonoscopy Study observation

104

0.96

0.00

1.4

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.94

0.00

1.4

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

0.00

-0.00

0.0

2.8

—

3.20

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

74.40

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

4.0

—

4.55

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.9

—

69.37

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

1.6

—

15.96

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

112.71

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.3

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.0

—

146.20

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(3020650) Glucose [Presence] in Urine

0.00

-0.00

0.0

1.2

—

0.00

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

11.4

—

993.60

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

669.60

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

69.20

—

(3009343) pH of Capillary blood

0.86

-0.00

1.6

3.1

7.41

7.43

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.2

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

4.0

—

9.88

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

10.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(44806071) Cardiolipin IgM antibody measurement

0.00

-0.00

0.0

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

67.31

—

(3024263) Appearance of Synovial fluid

0.00

-0.00

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.97

-0.00

1.7

1.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

111.00

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

29.20

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3028433) Virus identified in Specimen by Culture

0.00

-0.00

0.0

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.3

—

33.59

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

0.97

-0.00

2.7

1.9

62.84

67.36

g/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CONNSOFT_ABD and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_CONNSOFT_ABD	1.671 [1.13, 2.47]	0.01
Birth year	0.997 [0.99, 1.01]	0.464

During the follow-up period (1.1.1998 — 31.12.2019), 55 out of 382 females with CD2_BENIGN_CONNSOFT_ABD died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CONNSOFT_ABD.

N-year risk	Females	Males
1	0.156%	No data
5	1.052%	No data
10	2.632%	No data
15	4.982%	No data
20	8.626%	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CONNSOFT_ABD – Benign neoplasm: Connective and other soft tissue of abdomen

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Connective and other soft tissue of abdomen

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints